Viewing Study NCT01837095


Ignite Creation Date: 2025-12-24 @ 1:48 PM
Ignite Modification Date: 2025-12-29 @ 6:23 AM
Study NCT ID: NCT01837095
Status: COMPLETED
Last Update Posted: 2018-09-14
First Post: 2013-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
Sponsor: Polyphor Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module